tetano
Editor, Senior Moderator
Proc Natl Acad Sci U S A
. 2021 Feb 2;118(5):e2021615118.
doi: 10.1073/pnas.2021615118.
Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset
Varun Sasisekharan[SUP] 1 [/SUP], Niharika Pentakota[SUP] 1 [/SUP], Akila Jayaraman[SUP] 1 [/SUP], Kannan Tharakaraman[SUP] 1 [/SUP], Gerald N Wogan[SUP] 2 3 [/SUP], Uma Narayanasami[SUP] 4 [/SUP]
Affiliations
Abstract
Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the current pandemic remains a field of immense interest and active research worldwide. Although the severity of acute infection may depend on the intensity of innate and adaptive immunity, leading to higher morbidity and mortality, the longevity of IgG antibodies, including neutralizing activity to SARS-CoV-2, is viewed as a key correlate of immune protection. Amid reports and concern that there is a rapid decay of IgG antibody levels within 1 mo to 2 mo after acute infection, we set out to study the pattern and duration of IgG antibody response to various SARS-CoV-2 antigens in asymptomatic and symptomatic patients in a community setting. Herein, we show the correlation of IgG anti-spike protein S1 subunit, receptor binding domain, nucleocapsid, and virus neutralizing antibody titers with each other and with clinical features such as length and severity of COVID-19 illness. More importantly, using orthogonal measurements, we found the IgG titers to persist for more than 4 mo post symptom onset, implying that long-lasting immunity to COVID-19 from infection or vaccination might be observed, as seen with other coronaviruses such as SARS and Middle East respiratory syndrome.
Keywords: SARS-CoV-2; antigens; immunity; orthogonal.
. 2021 Feb 2;118(5):e2021615118.
doi: 10.1073/pnas.2021615118.
Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset
Varun Sasisekharan[SUP] 1 [/SUP], Niharika Pentakota[SUP] 1 [/SUP], Akila Jayaraman[SUP] 1 [/SUP], Kannan Tharakaraman[SUP] 1 [/SUP], Gerald N Wogan[SUP] 2 3 [/SUP], Uma Narayanasami[SUP] 4 [/SUP]
Affiliations
- PMID: 33446512
- DOI: 10.1073/pnas.2021615118
Abstract
Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the current pandemic remains a field of immense interest and active research worldwide. Although the severity of acute infection may depend on the intensity of innate and adaptive immunity, leading to higher morbidity and mortality, the longevity of IgG antibodies, including neutralizing activity to SARS-CoV-2, is viewed as a key correlate of immune protection. Amid reports and concern that there is a rapid decay of IgG antibody levels within 1 mo to 2 mo after acute infection, we set out to study the pattern and duration of IgG antibody response to various SARS-CoV-2 antigens in asymptomatic and symptomatic patients in a community setting. Herein, we show the correlation of IgG anti-spike protein S1 subunit, receptor binding domain, nucleocapsid, and virus neutralizing antibody titers with each other and with clinical features such as length and severity of COVID-19 illness. More importantly, using orthogonal measurements, we found the IgG titers to persist for more than 4 mo post symptom onset, implying that long-lasting immunity to COVID-19 from infection or vaccination might be observed, as seen with other coronaviruses such as SARS and Middle East respiratory syndrome.
Keywords: SARS-CoV-2; antigens; immunity; orthogonal.